Andrew Koenig

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

Paul Emery, Ferdinand C. Breedveld, Stephen Hall et al. · The Lancet · 2008 · 817 citations

Medicine, Pharmacology, Pharmacotherapy +9

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Josef S Smolen, Peter Nash, Patrick Durez et al. · The Lancet · 2013 · 354 citations · Full text

Medicine, Immunology, Pharmacotherapy +9

Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

Maxime Dougados, Désirée van der Heijde, Joachim Sieper et al. · Arthritis & Rheumatology · 2014 · 226 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double-blind trial

Jürgen Braun, Irene van der Horst‐Bruinsma, Feng Huang et al. · Arthritis & Rheumatism · 2011 · 155 citations

Medicine, Clinical Sciences, Pharmacotherapy +11

Study of Tofacitinib in Refractory Dermatomyositis: An Open‐Label Pilot Study of Ten Patients

Julie J. Paik, Livia Casciola‐Rosen, Joseph Shin et al. · Arthritis & Rheumatology · 2020 · 153 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15